RT Journal Article
SR Electronic
T1 Spatio-temporal associations between deforestation and malaria incidence in Lao PDR
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.23.20072215
DO 10.1101/2020.04.23.20072215
A1 Francois Rerolle
A1 Emily Dantzer
A1 Andrew A. Lover
A1 John M. Marshall
A1 Bouasy Hongvanthong
A1 Hugh JW. Sturrock
A1 Adam Bennett
YR 2020
UL http://medrxiv.org/content/early/2020/05/07/2020.04.23.20072215.abstract
AB As countries in the Greater Mekong Sub-region (GMS) increasingly focus their malaria control and elimination efforts on forest-going populations, greater understanding of the relationship between deforestation and malaria incidence will be essential for programs to assess and meet their 2030 elimination goals. Leveraging village-level health facility surveillance data and forest cover data in a spatio-temporal modeling framework, we found evidence that deforestation is associated with short-term increases, but long-term decreases in confirmed malaria case incidence in Lao People’s Democratic Republic (Lao PDR). We identified strong associations with deforestation measured within 30 km of villages but not with deforestation in the near (10 km) and immediate (1 km) vicinity. Results appear driven by deforestation in densely forested areas and were more pronounced for infections with Plasmodium falciparum (P. falciparum) than for Plasmodium vivax (P. vivax). These findings highlight the influence of forest-going populations on malaria transmission in the GMS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementStudy funded by the Bill & Melinda Gates Foundation (Grant ID OPP1116450).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated and analyzed in this study have been uploaded with the submission.